Table of Contents
Licensing
| Gilead Lands Galapagos’ Filgotinib After AbbVie Walks Away | Abstract pdf html |
| Heather Cartwright & Keshav Mahawar |
| Eisai Bolsters Oncology Pipeline by Acquiring Rights to Huya’s Cancer Drug | Abstract pdf html |
| Jasmine Kalsi & Taskin Ahmed |
| Takeda Demonstrates Long-term Commitment to Antibody Drug Conjugates in Oncology With its Expanded Agreement With Mersana Therapeutics | Abstract pdf html |
| Natasha Berry |
This work is licensed under a Creative Commons Attribution 3.0 License.